AccurKardia
New York, NY
AccurKardia delivers automated clinical-grade ECG interpretation software to cardiac monitoring companies, thereby expanding access to the benefits of remote cardiac care to millions of patients worldwide. AccurKardia combines proprietary AI and non-AI based techniques to provide near-real time ECG analytics in the cloud, on device, and at the edge. The Company is part of Cohort 3 of Mayo Clinic Platform_Accelerate and first 510(k) filing is under review by FDA.
accurkardia.comCompany Details
Founded
- 2019
Employees
- Between 10 - 20 employees
Raised
- $6,270,000
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Juan C Jimenez
Founders
- John FoxMohamed Sadeq AliJuan C JimenezTony M KuttiachenNaveen Srinivas
Company Collections
These are collections AccurKardia is a part of. Click on the collection name to view similar companies.
AccurKardia's Industries
AccurKardia Headquarters Location
Total Amount Raised: $6,270,000
AccurKardia Funding Rounds
Seed
$2,000,000
Seed
$2,700,000
Seed Investors
PopularMayo ClinicPre Seed
$500,000
Pre Seed
$340,000
Pre Seed
$570,000
Pre Seed
$160,000
Pre Seed Investors
Root NYC
AccurKardia Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on AccurKardia.